Kiromic BioPharma

KRBP42

Penny Stock

$1.42arrow_drop_down10.12%-$0.16

Penny Stock

KRBP42

$1.42

arrow_drop_down10.12%-$0.16

Penny Stock

Performance History

Key Stats
Open	$1.56
Prev. Close	$1.58
EPS	-6.29
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.31M
PE Ratio	-

	LOW	HIGH
Day Range	1.42	1.56
52 Week Range	0.16	3.78

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-6.29

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Kiromic BioPharma (KRBP)

Kiromic BioPharma Inc (KRBP) is a pharmaceutical company focused on developing innovative targeted therapies for cancer treatment. With a commitment to precision medicine, Kiromic BioPharma aims to revolutionize the way cancer is treated by utilizing advanced technologies such as genomics and immunotherapy. The company's mission is to provide personalized therapies that target the specific genetic alterations driving each patient's cancer. By tailoring treatment to the individual, Kiromic BioPharma hopes to improve patient outcomes and reduce the side effects associated with traditional chemotherapy.

One of the key strengths of Kiromic BioPharma is its comprehensive approach to cancer research. The company has built a diverse portfolio of targeted therapies that address a wide range of cancer types. Through strategic partnerships and collaborations, Kiromic BioPharma has access to cutting-edge technologies and expertise, which enables rapid development and validation of its therapeutic candidates. With a strong pipeline of innovative therapies, the company is well-positioned to capitalize on the growing demand for personalized cancer treatments.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Pietro Bersani CPA, J.D.
Headquarters: Houston
Employees: 31
Exchange: NASDAQ

Keep an eye on Kiromic BioPharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Kiromic BioPharma 's (KRBP) price per share?

The current price per share for Kiromic BioPharma (KRBP) is $1.42. The stock has seen a price change of -$0.16 recently, indicating a -10.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Kiromic BioPharma (KRBP)?

For Kiromic BioPharma (KRBP), the 52-week high is $3.78, which is 166.2% from the current price. The 52-week low is $0.16, the current price is 787.5% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Kiromic BioPharma (KRBP) a growth stock?

Kiromic BioPharma (KRBP) has shown an average price growth of 0.41% over the past three years. It has received a score of -1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Kiromic BioPharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Kiromic BioPharma (KRBP) stock price performance year to date (YTD)?

As of the latest data, Kiromic BioPharma (KRBP) has a year-to-date price change of 53.51%. Over the past month, the stock has experienced a price change of -34.56%. Over the last three months, the change has been -45.38%. Over the past six months, the figure is -48.36%.

help

Is Kiromic BioPharma (KRBP) a profitable company?

Kiromic BioPharma (KRBP) has a net income of -$20.95M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$19.94M. Furthermore, the EBITDA is -$20.11M.

help

What is the market capitalization of Kiromic BioPharma (KRBP)?

Kiromic BioPharma (KRBP) has a market capitalization of $2.32M. The average daily trading volume is 820, indicating the stock's liquidity and investor engagement.